ID-8 100 mg | Purity Not Available
TargetMol
ID-8, a DYRK inhibitor, sustains embryonic stem cell self-renewal in long-term culture.
More Information Supplier PageID-8
Search Results
Nalfurafine hydrochloride 1 mg | 99.88%
TargetMol
Nalfurafine(TRK-820) is an opioid κ-selective agonist; has been approved in Japan for treatment of itch in patients with chronic kidney disease.
More Information Supplier PageNalfurafine hydrochloride
Edoxaban 100 mg | Purity Not Available
TargetMol
Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with K i s of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and is able to be used for stroke prevention. Edoxaban is a also weak inhibitor of thrombin and factor IXaβ (FIXa), […]
More Information Supplier PageEdoxaban
Pilaralisib 100 mg | 98.24%
TargetMol
Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
More Information Supplier PagePilaralisib
Pilaralisib 50 mg | 98.24%
TargetMol
Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
More Information Supplier PagePilaralisib
Pilaralisib 10 mg | 98.24%
TargetMol
Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K). Pilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others.
More Information Supplier PagePilaralisib
PI-3065 25 mg | Purity Not Available
TargetMol
PI-3065
kb NB 142-70 2 mg | Purity Not Available
TargetMol
kb NB 142-70 is a selective protein kinase D (PKD) inhibitor (IC50 values are 28.3, 58.7 and 53.2 nM for PKD1, 2 and 3 respectively).
More Information Supplier Pagekb NB 142-70
PF-06447475 100 mg | 99.62%
TargetMol
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively.
More Information Supplier PagePF-06447475
PF-06447475 25 mg | 99.62%
TargetMol
PF-06447475 is a highly effective, specific, brain penetrant LRRK2 inhibitor with IC0 of 3/11 nM for wild type LRRK2 and G2019S LRRK2 respectively.
More Information Supplier PagePF-06447475